Pharmaceuticals & Biotech

Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.

  • 7 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Pharmaceuticals & Biotech

Discovery & Preclinical Targets, assays, animal models, and early safety/tox studies before human trials. Clinical Trials (Phases I–IV) Design, endpoints, enrollment, interim reads, and post‑market surveillance. Approvals, Safety & REMS FDA/EMA decisions, boxed warnings, pharmacovigilance, and label changes. Generics & Biosimilars Access, interchangeability, litigation, and pricing dynamics for follow‑ons. Vaccines & Immunization Platforms (mRNA, viral vector), boosters, schedules, and cold‑chain supply. Cell & Gene Therapies CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up. Manufacturing & Supply APIs, sterile fill‑finish, shortages, and quality systems across the supply chain.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals & Biotech


openpr.com > news > 4631015 > follicular-lymphoma-market-to-expand-rapidly-with-advancing

Follicular Lymphoma Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 - DelveInsight

1+ hour, 35+ min ago   (62+ words) Follicular Lymphoma Market to Expand Rapidly with Advancing openpr.com Follicular Lymphoma Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 - DelveInsight Press release from: DelveInsight Business Research Permanent link to this press release: You can edit…...


buffalonews.com > news > nation-world > article_1eec3004-8a2c-4341-9edc-5c330eb05b9b.html

Why mRNA vaccines are giving cancer patients hope

35+ min ago   (187+ words) Buffalo News Javascript is required to use this website. Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead. This story was originally published by PolitiFact. People…...


secretnyc.co > nyc-covid-vaccine

COVID hospitalizations are officially rising in NYC: Here is what to know about the ‘updated’ vaccines

2+ hour, 55+ min ago   (256+ words) While the FDA has narrowed its primary guidance to seniors and high-risk groups, local health officials emphasize that climbing RSV numbers and alarming wastewater trends mean all New Yorkers should secure their free shots According to recent state data, COVID-related…...


mynewberrynews.com > community > new-federal-vaccine-order-wont-change-michigan-schedules

New federal vaccine order won't change Michigan schedules

3+ hour, 38+ min ago   (519+ words) Sep 14, 2026 | Community By Michael G. Beaulieu, MD Medical Director, LMAS District Health Department Many parents have recently heard about a new executive order from the White House concerning childhood vaccines. The order, signed August 10, 2026, has generated questions about whether children should…...


biopharmadive.com > news > summit-akeso-wclc-2026-ivonescimab-lung-cancer-survival > 830318

Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results

11+ hour, 54+ min ago   (474+ words) As dueling data emerge between their drug ivonescimab and a rival Merck medication, Summit and Akeso revealed new findings that impressed Wall Street. Akeso and Summit Therapeutics’ experimental dual-acting cancer drug helped people with lung cancer live about eight months…...


seekingalpha.com > news > 4642676-johnson-and-johnson-contineum-depression-candidate-fails-phase-2

J&J/Contineum depression candidate fails in phase 2

46+ min ago   (18+ words) J&J’s JNJ-5120 (PIPE-307) missed its phase 2 MOONLIGHT-1 primary endpoint in major depressive disorder. Read more here....


usatoday.com > story > money > money-management > healthcare > 09/14/2026 > ai-medical-innovation-healthcare > 91713919007

AI innovation is reshaping healthcare from diagnosis to drug discovery

9+ hour, 26+ min ago   (486+ words) In science fiction, futuristic medical technology often appears in a doctor’s hand. Think of Dr. McCoy scanning a patient using a tricorder wand in Star Trek. These innovations are making diagnosis faster. But can they make it better? Early evidence…...


freedom959.net > 09/14/2026 > lilly-says-foundayo-has-captured-over-30-of-new-us-patients-on-oral-weight-loss-drugs

Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugs

57+ min ago   (323+ words) Sept 14 (Reuters) – Eli Lilly on Monday said it has captured more than 30% of new patients in the U.S. market for oral obesity treatments, narrowing the early ​lead gained by Danish rival Novo Nordisk with its ‌Wegovy pill. Novo CEO Mike…...


medpagetoday.com > neurology > generalneurology > 122994

First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval

2+ hour, 20+ min ago   (7+ words) Motor function may improve with adjunctive apitegromab...


pymnts.com > healthcare > 2026 > modernas-ai-built-cancer-vaccine-clears-phase-3-with-merck

Moderna???s AI-Built Cancer Vaccine Clears Phase 3 With Merck

1+ hour, 28+ min ago   (126+ words) Moderna’s AI reads a patient’s own tumor, decides which mutations to target and builds a treatment that exists nowhere else. The therapy delivered the first positive Phase 3 result for a cancer treatment designed for a single patient. The real challenge…...